The selectivty and anti-metastatic activity of oral bioavailable butyric acid prodrugs-Reference-Cited by-同舟云学术

The selectivty and anti-metastatic activity of oral bioavailable butyric acid prodrugs

Published:2006-02-24 Issue:5 Volume:24 Page:383-392
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Rephaeli Ada,Entin-Meer Michal,Angel Dikla,Tarasenko Nataly,Gruss-Fischer Tal,Bruachman Irena,Phillips Don R.,Cutts Suzanne M.,Haas-Kogan Daphne,Nudelman Abraham

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10637-006-6213-1.pdf

Reference23 articles.

1. Ashton RW, Jett JR (2005) Screening for non-small cells lung cancer. Semin Oncol 32:253–258

2. Rephaeli A, Shaklai M, Ruse M, Nudelman A (1991) Derivatives of butyric acid as potential anti-neoplastic agents. Int J Cancer 49:66–72

3. Rabizadeh E, Shaklai M, Nudelman A (1993) Eisenbach L, Rephaeli A: Rapid alteration of c-myc and c-jun expression in leukemic cells induced to differentiate by a butyric acid prodrug. FEBES Lett 328:225–229

4. Aviram A, Zimrah Y, Shaklai M, Nudelman A, Rephaeli A (1994) Comparison between the effect of butyric acid and its prodrug pivaloyloxymethyl butyrate on histones hyperacetylation in an HL-60 leukemic cell line. Int J Cancer 56:906–909

5. Zimra Y, Nudelman A, Zhuk R, Rabizadeh E, Shaklai M, Aviram A, Rephaeli A (2000) Uptake of acyloxyalkyl ester prodrugs of butyric acid into leukemic cells and their intracellular esterase-catalyzed hydrolysis. J Cancer Res Clin Oncol 123:152–160

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing and delivering microbial metabolites as therapeutics via advanced pharmaceutical approaches;Pharmacology & Therapeutics;2024-04

2. Advances in the Delivery and Development of Epigenetic Therapeutics for the Treatment of Cancer;Molecular Pharmaceutics;2023-10-30

3. An evaluation of the interaction of pixantrone with formaldehyde-releasing drugs in cancer cells;Cancer Chemotherapy and Pharmacology;2022-04-23

4. Formaldehyde-doxorubicin dual polymeric drug delivery system for higher efficacy and limited cardiotoxicity of anthracyclines;European Polymer Journal;2021-01

5. Histone deacetylase inhibitor based prodrugs;European Journal of Medicinal Chemistry;2020-10